Lack of Evidence of Lower 30-Day All-Cause Readmission in Medicare Beneficiaries With Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone
International Journal of Cardiology - Ireland
doi 10.1016/j.ijcard.2016.11.006
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Elsevier BV